Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody Mediated Rejection After Kidney Transplantation”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Not applicableUnknownNCT03436134
What this trial is testing

Treatment of Chronic Active Antibody Mediated Rejection After Kidney Transplantation by Double-Filtration PlasmaPheresis or Plasma Exchange

Who this might be right for
Kidney TransplantationAntibody Mediated Rejection
University Hospital, Grenoble 16
Large-scale testing (Phase 3)Not Yet RecruitingNCT06291103
What this trial is testing

Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R)

Who this might be right for
Kidney Transplant Rejection
University Hospital, Rouen 290
Not applicableLooking for participantsNCT07134491
What this trial is testing

Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity

Who this might be right for
Antibody Mediated Rejection After Kidney Transplantation
Assistance Publique - Hôpitaux de Paris 45
Testing effectiveness (Phase 2)Looking for participantsNCT06744647
What this trial is testing

Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation

Who this might be right for
Antibody-Mediated RejectionKidney TransplantationBiopsy-proven Histologic Scores+1 more
Alexion Pharmaceuticals, Inc. 45
Not applicableStudy completedNCT04057742
What this trial is testing

AlloSure for the Monitoring of Antibody Mediated Processes After Kidney Transplantation

Who this might be right for
Kidney Transplant Failure and Rejection
University of Wisconsin, Madison 52
Testing effectiveness (Phase 2)UnknownNCT02563340
What this trial is testing

Effect of BM-MSCs on Chronic AMR After Kidney Transplantation

Who this might be right for
Kidney Transplantation
First Affiliated Hospital, Sun Yat-Sen University 60
Not applicableUnknownNCT03916822
What this trial is testing

Cell-based Assays for Antibody-mediated Transplant Rejection

Who this might be right for
Antibody-Mediated Graft Rejection
Plexision 30
Not applicableUnknownNCT06013358
What this trial is testing

DdcfDNA in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Seoul National University Hospital 200
Testing effectiveness (Phase 2)Study completedNCT02426684
What this trial is testing

Ides in Highly Sensitized (HS) Patients Awaiting Kidney Transplantation

Who this might be right for
Renal Disease
Cedars-Sinai Medical Center 17
Testing effectiveness (Phase 2)Study completedNCT01134510
What this trial is testing

Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection

Who this might be right for
Kidney Transplantation
Stanley Jordan, MD 20
Testing effectiveness (Phase 2)Study completedNCT03444103
What this trial is testing

A Pilot Trial of Clazakizumab in Late ABMR

Who this might be right for
Antibody-mediated Rejection
Medical University of Vienna 20
Testing effectiveness (Phase 2)Ended earlyNCT01895127
What this trial is testing

Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation

Who this might be right for
Antibody-mediated RejectionHumoral Rejection
Brigham and Women's Hospital 11
Large-scale testing (Phase 3)Enrolling By InvitationNCT06801886
What this trial is testing

Silymarin's Advantage on Graft Effectiveness

Who this might be right for
Posttransplant Diabetes MellitusAcute Graft RejectionBiopsy Proven Acute Rejection+2 more
University Hospital, Martin 130
Not applicableEnded earlyNCT04711850
What this trial is testing

An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR

Who this might be right for
Kidney Transplant Rejection
Hansa Biopharma AB 18
Testing effectiveness (Phase 2)Study completedNCT03380377
What this trial is testing

Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant

Who this might be right for
Antibody-mediated RejectionKidney Transplant; ComplicationsTransplant Glomerulopathy+3 more
Stanley Jordan, MD 10
Not applicableUnknownNCT04368962
What this trial is testing

DSA Risk Factors in MMF-based Immunosuppressed Post-transplanted Patients

Who this might be right for
Antibody-mediated Rejection
First Affiliated Hospital Xi'an Jiaotong University 300